These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 6430642)

  • 61. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
    Landgren BM; Johannisson E; Xing S; Aedo AR; Diczfalusy E
    Contraception; 1985 Dec; 32(6):581-601. PubMed ID: 3937664
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Changes in physiological, EEG and psychological parameters in women during the spontaneous menstrual cycle and following oral contraceptives.
    Becker D; Creutzfeldt OD; Schwibbe M; Wuttke W
    Psychoneuroendocrinology; 1982; 7(1):75-90. PubMed ID: 7100370
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of oral contraceptives on integrated secretion of gonadotropins.
    Dericks-Tan JS; Gudacker V; Taubert HD
    Contraception; 1992 Oct; 46(4):369-77. PubMed ID: 1486775
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of follicular growth and luteal function of "missing the pill". A comparison between a monophasic and a triphasic combined oral contraceptive.
    Landgren BM; Csemiczky G
    Contraception; 1991 Feb; 43(2):149-59. PubMed ID: 1828225
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
    Russowsky M; Sartoretto JN
    Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels.
    Ory SJ; Hammond CB; Yancy SG; Hendren RW; Pitt CG
    Am J Obstet Gynecol; 1983 Mar; 145(5):600-5. PubMed ID: 6402933
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phasic approach to oral contraceptives.
    Hale RW
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1052-8. PubMed ID: 3118718
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Contraception; 1980 Mar; 21(3):225-33. PubMed ID: 6771090
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen.
    Archer DF; Kovalevsky G; Ballagh SA; Grubb GS
    Contraception; 2009 Sep; 80(3):245-53. PubMed ID: 19698816
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
    Hamerlynck JV; Vollebregt JA; Doornebos CM; Muntendam P
    Contraception; 1987 Mar; 35(3):199-205. PubMed ID: 2956054
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
    Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
    Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ovarian follicles during oral contraceptive cycles: their potential for ovulation.
    Killick SR
    Fertil Steril; 1989 Oct; 52(4):580-2. PubMed ID: 2680616
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking.
    Kanarkowski R; Tornatore KM; D'Ambrosio R; Gardner MJ; Jusko WJ
    Clin Pharmacol Ther; 1988 Jan; 43(1):23-31. PubMed ID: 3121231
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of ovulation by low-dose monophasic contraceptive containing gestodene.
    Thomas K; Vankrieken L
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1404-10. PubMed ID: 2121037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.